In a recent study, DPSCs were found to inhibit the proliferation of CD4+ T lymphocytes by increasing the expression of the Fas ligand in T lymphocytes and Foxp3 expression in Treg cells and reducing intracellular IFN-γ and IL-17 secretion in SS patients [57]. This evidence concerns the gene FASLG and synovial sarcoma.